Exome Asset Management LLC Replimune Group, Inc. Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
A detailed history of Exome Asset Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 294,846 shares of REPL stock, worth $2.65 Million. This represents 2.56% of its overall portfolio holdings.
Number of Shares
294,846
Previous 54,738
438.65%
Holding current value
$2.65 Million
Previous $663 Million
333.68%
% of portfolio
2.56%
Previous 0.5%
Shares
2 transactions
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$99.2 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$97.5 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$44 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$42.3 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$35.1 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $443M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...